Showing results (851-860 of 2,609) with videos related to

Sort By:
Pageof 261
Oncology Research|December 16, 1998
Differential effect of interleukin 10 on interleukin 12- and interleukin 2-mediated killer induction from blood mononuclear cellsK Pai, H Yanagawa, E Takauchi, et al.
Oncology Research|December 16, 1998
Spatial and temporal expression of angiogenic molecules during tumor growth and progressionR Kumar, H Kuniyasu, C D Bucana, et al.
Oncology Research|December 16, 1998
Tamoxifen downregulates signal transduction and is synergistic with tiazofurin in human breast carcinoma MDA-MB-435 cellsF Shen, G Weber
Oncology Research|January 1, 1996
Expression and characterization of the multidrug resistance-associated protein in insect cells infected with a recombinant baculovirusH Sun, Q Zhu, M S Center
Oncology Research|January 1, 1996
Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell linesM Wang, K Fudge, J S Rhim, et al.
Oncology Research|January 1, 1996
Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing miceK Motoki, K Maeda, H Ueno, et al.
Oncology Research|January 1, 1996
Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissuesH L Asch, E Eliacin, T G Fanning, et al.
Oncology Research|January 1, 1996
Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influxL Drew, N Groome, J R Warr, et al.
Oncology Research|February 24, 2006
Overexpression of extracellular superoxide dismutase (EC-SOD) in mouse skin plays a protective role in DMBA/TPA-induced tumor formationSung-Hyun Kim, Myoung-Ok Kim, Peng Gao, et al.
Oncology Research|February 24, 2006
Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoterMonica Borgatti, Douglas D Boyd, Ilaria Lampronti, et al.
Pageof 261